Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viatris Inc. - Common Stock
(NQ:
VTRS
)
9.240
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,269
Open
9.240
Bid (Size)
9.200 (1)
Ask (Size)
9.320 (5)
Prev. Close
9.240
Today's Range
9.240 - 9.240
52wk Range
8.770 - 13.55
Shares Outstanding
1,212,301,241
Dividend Yield
5.19%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
Today 5:01 EDT
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at generic pharmaceuticals stocks, starting...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Securities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
March 12, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Performance
YTD
-25.60%
-25.60%
1 Month
-12.99%
-12.99%
3 Month
-27.53%
-27.53%
6 Month
-18.52%
-18.52%
1 Year
-23.38%
-23.38%
More News
Read More
Viatris Inc. (VTRS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 12, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Forecasting The Future: 4 Analyst Projections For Viatris
March 05, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
Securities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 11, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
1 Healthcare Stock to Target This Week and 2 to Turn Down
March 11, 2025
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
March 09, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
March 05, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
March 05, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Explore the top gainers and losers within the S&P500 index in today's session.
March 03, 2025
Via
Chartmill
Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
March 02, 2025
Via
Benzinga
Stay informed with the top movers within the S&P500 index on Thursday.
February 27, 2025
Via
Chartmill
Why Viatris (VTRS) Shares Are Falling Today
February 27, 2025
Via
StockStory
What's going on in today's session: S&P500 most active stocks
February 27, 2025
Via
Chartmill
Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook
February 27, 2025
Via
Benzinga
Topics
Earnings
Exposures
Financial
Product Safety
Discover which S&P500 stocks are making waves on Thursday.
February 27, 2025
Via
Chartmill
Gapping S&P500 stocks in Thursday's session
February 27, 2025
Via
Chartmill
Viatris Misses Estimates, Cash Flow Up
February 27, 2025
Via
The Motley Fool
Get insights into the top movers in the S&P500 index of Thursday's pre-market session.
February 27, 2025
Via
Chartmill
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow
February 27, 2025
Via
StockStory
Viatris (NASDAQ:VTRS) Misses Q4 Revenue Estimates, Stock Drops
February 27, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Viatris Earnings: What To Look For From VTRS
February 26, 2025
Via
StockStory
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
February 21, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
February 19, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
